DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,275,350 | +1.6% | 21,263 | -1.7% | 0.36% | +5.3% |
| Q2 2023 | $5,192,880 | -4.1% | 21,637 | +0.7% | 0.34% | -10.6% |
| Q1 2023 | $5,412,811 | -5.5% | 21,476 | -0.4% | 0.38% | -10.0% |
| Q4 2022 | $5,725,640 | +2.6% | 21,572 | -0.2% | 0.42% | -5.0% |
| Q3 2022 | $5,581,000 | +1.2% | 21,607 | -0.7% | 0.44% | +4.7% |
| Q2 2022 | $5,516,000 | -13.2% | 21,758 | +0.5% | 0.42% | -1.9% |
| Q1 2022 | $6,353,000 | -12.5% | 21,658 | -1.8% | 0.43% | -6.1% |
| Q4 2021 | $7,257,000 | +8.7% | 22,059 | +0.6% | 0.46% | -3.6% |
| Q3 2021 | $6,677,000 | +11.8% | 21,934 | -1.4% | 0.48% | +14.2% |
| Q2 2021 | $5,971,000 | +18.6% | 22,249 | -0.5% | 0.42% | +10.3% |
| Q1 2021 | $5,033,000 | +3.9% | 22,360 | +2.5% | 0.38% | -2.3% |
| Q4 2020 | $4,845,000 | +4.1% | 21,811 | +1.0% | 0.39% | -9.4% |
| Q3 2020 | $4,652,000 | +19.6% | 21,603 | -1.8% | 0.43% | +10.9% |
| Q2 2020 | $3,891,000 | -26.7% | 22,001 | -42.7% | 0.38% | -22.7% |
| Q1 2020 | $5,311,000 | -2.9% | 38,377 | +7.7% | 0.50% | +20.3% |
| Q4 2019 | $5,470,000 | +12.3% | 35,644 | +5.7% | 0.41% | +5.6% |
| Q3 2019 | $4,871,000 | +2.4% | 33,728 | +1.4% | 0.39% | -1.0% |
| Q2 2019 | $4,755,000 | +8.4% | 33,274 | +0.2% | 0.40% | +4.8% |
| Q1 2019 | $4,385,000 | +30.1% | 33,214 | +1.6% | 0.38% | +15.6% |
| Q4 2018 | $3,370,000 | -4.6% | 32,681 | +0.5% | 0.33% | +9.4% |
| Q3 2018 | $3,533,000 | +7.5% | 32,516 | -2.4% | 0.30% | +1.0% |
| Q2 2018 | $3,288,000 | +2.6% | 33,329 | +1.8% | 0.30% | -2.6% |
| Q1 2018 | $3,205,000 | +5.0% | 32,728 | -0.5% | 0.30% | +7.1% |
| Q4 2017 | $3,052,000 | +10.6% | 32,885 | +2.2% | 0.28% | +3.3% |
| Q3 2017 | $2,759,000 | +1.2% | 32,166 | -0.4% | 0.27% | -2.1% |
| Q2 2017 | $2,726,000 | +5.3% | 32,308 | +6.8% | 0.28% | 0.0% |
| Q1 2017 | $2,588,000 | +15.2% | 30,262 | +4.8% | 0.28% | +8.1% |
| Q4 2016 | $2,247,000 | +1.1% | 28,876 | +1.9% | 0.26% | -7.2% |
| Q3 2016 | $2,222,000 | -18.0% | 28,345 | +5.7% | 0.28% | -22.5% |
| Q2 2016 | $2,709,000 | +5.3% | 26,815 | -1.1% | 0.36% | 0.0% |
| Q1 2016 | $2,573,000 | +3.0% | 27,122 | +0.8% | 0.36% | +0.6% |
| Q4 2015 | $2,499,000 | +9.7% | 26,902 | +0.6% | 0.36% | +0.8% |
| Q3 2015 | $2,278,000 | +1.1% | 26,738 | +1.5% | 0.36% | +8.2% |
| Q2 2015 | $2,254,000 | +2.8% | 26,340 | +2.0% | 0.33% | +2.8% |
| Q1 2015 | $2,192,000 | +2.6% | 25,818 | +3.6% | 0.32% | +2.2% |
| Q4 2014 | $2,136,000 | +11.0% | 24,928 | -1.6% | 0.31% | +7.2% |
| Q3 2014 | $1,924,000 | -2.4% | 25,326 | +1.1% | 0.29% | -4.3% |
| Q2 2014 | $1,972,000 | +3.1% | 25,046 | -1.7% | 0.30% | -2.9% |
| Q1 2014 | $1,912,000 | -2.4% | 25,491 | +0.5% | 0.31% | -4.6% |
| Q4 2013 | $1,959,000 | +10.2% | 25,376 | -1.1% | 0.33% | +0.6% |
| Q3 2013 | $1,778,000 | +12.5% | 25,655 | +2.7% | 0.33% | +5.5% |
| Q2 2013 | $1,581,000 | – | 24,972 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |